BridgeBio Pharma, Inc. ($BBIO)
Valantine Hannah โ Director
Shares
8,671
Price
$72.00
Total Value
$624,312.00
Nearby Earnings
Feb 24, 2026
EPS:Est: -0.75
Revenue:Est: $149.07M
Transaction Details
| Insider | Valantine Hannah |
|---|---|
| Title | Director |
| Transaction Date | Mar 10, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Mar 12, 2026 |
| Shares Sold | 8,671 |
| Price per Share | $72.00 |
| Total Value | $624,312.00 |
| Shares Owned After | 7,465 |
| Derivative | No |
| Accession Number | 0001470831-26-000260 |
| Document | View SEC Filing |